Treatment Program for PTSD

We are building upon successful foundational research that established a successful cure for PTSD in a rodent model.  This piloted PTSD treatment in rodents consisted of a surgical intervention shortly after a traumatic event to decrease GluA1 levels, and therefore functional AMPA receptors, in the amygdala to non-PTSD levels. Testing in the rodent model effected a complete reversal of PTSD without amnesia for the triggering trauma.

We are now developing a non-invasive oral treatment for PTSD. Unlike existing PTSD treatments, which typically temporarily suppress symptoms, we target the biological cause of PTSD—an up-regulation of a receptor protein in the region of the brain responsible for fear learning. Our small molecule drug discovery program began in Spring 2017, with initial hit identification expected in early 2020.

FUNDING & PARTNERS